Featured

Novartis to Acquire Avidity Biosciences for $12 Billion

Novartis AG will acquire Avidity Biosciences for USD 72.00 per share in cash, valuing the company at approximately USD 12.0 billion. Avidity will sepa...

October 27, 2025

Latest Merger & Acquisitions

No items found.

No items found.

Other Merger & Acquisitions Updates

Novartis to Acquire Avidity Biosciences for $12 Billion

October 27, 2025

Innovent and Takeda Partner to Develop Next-Gen IO and ADC Therapies

October 22, 2025

Boehringer Ingelheim and AimedBio Collaborate to Advance Novel ADC Therapy for Broad Range of Cancers

October 16, 2025

Biocon Biologics and Civica Expand Partnership to Launch Insulin Glargine for U.S. Diabetes Patients

October 16, 2025

Novo Nordisk to Acquire Akero Therapeutics for up to $5.2 Billion

October 9, 2025

MaxCyte and Moonlight Bio Partner to Advance T Cell Therapies for Solid Tumors

October 7, 2025

Elutia Closes BioEnvelope Business Sale to Boston Scientific for $88 Million, Focuses on NXT-41x for Breast Reconstruction Infections

October 2, 2025

Roche to Acquire 89bio for MASH Therapy Development

September 18, 2025

Novartis Acquires Tourmaline Bio for $1.4 Billion, Expanding Cardiovascular Pipeline with Pacibekitug

September 9, 2025

Zydus and Synthon Partner for Ozanimod Capsules in the US Market

September 5, 2025

Polpharma Biologics and MS Pharma Partner to Commercialize Biosimilars in MENA

September 2, 2025

Servier and IDEAYA Biosciences Partner to Develop Darovasertib for Uveal Melanoma

September 2, 2025

LakeShore Biopharma Receives Revised Acquisition Proposal

August 29, 2025

AbbVie Acquires Gilgamesh Pharmaceuticals' Bretisilocin for Major Depressive Disorder

August 26, 2025

AbbVie Acquires Capstan Therapeutics and its Novel CAR-T Therapy Candidate

August 20, 2025

AleraCare and PURE Healthcare to Merge, Creating a Leading Ambulatory Infusion Platform

August 14, 2025

Melinta Therapeutics Acquired by CorMedix for $300 Million

August 7, 2025

CorMedix to Acquire Melinta Therapeutics, Expanding its Specialty Pharmaceutical Portfolio

August 7, 2025

Demetra Acquires OrthoFundamentals and Launches Global Spine Division

August 4, 2025

Sanofi Acquires Rights to Arrowhead's Plozasiran for Hypertriglyceridemia in Greater China

August 4, 2025

Mallinckrodt and Endo Merger Creates Global Therapeutics Leader

August 4, 2025

Hengrui Pharma and GSK Partner to Develop Up to 12 Innovative Medicines

July 28, 2025

Adaptimmune Sells Cell Therapies to US WorldMeds for $55 Million

July 28, 2025

Gate Bioscience and Lilly Partner to Develop Molecular Gate Medicines

July 25, 2025

Thermo Fisher and Sanofi Expand Partnership: Acquisition of Sterile Drug Manufacturing Site

July 17, 2025

Repare Therapeutics Outlicenses Lunresertib to Debiopharm

July 16, 2025

Cantargia Licenses CAN10 IL1RAP Immunology Program to Otsuka Pharmaceutical

July 15, 2025

Sartorius Stedim Biotech and Sensible Biotechnologies Partner to Scale Up mRNA Manufacturing

July 10, 2025

Merck Acquires Verona Pharma for $10 Billion, Expanding COPD Treatment Portfolio

July 9, 2025

Chugai and Gero Partner to Develop Novel Therapies for Age-Related Diseases

July 8, 2025

Ligand Completes Merger with Channel Therapeutics, Launching ZELSUVMI™ for Molluscum Contagiosum

July 3, 2025

EnChannel Medical Acquires Acutus Medical's AcQMap™ Electrophysiology Assets

July 2, 2025

Biofrontera Inc. Acquires US Rights to Ameluz® and RhodoLED®, Secures $11 Million Investment

July 1, 2025

23andMe Sold to TTAM Research Institute for $305 Million

June 30, 2025

Fujirebio Acquires Plasma Services Group, Strengthening its Biomaterials Supply

June 23, 2025

RyboDyn Joins Lilly Gateway Labs to Advance Next-Gen Immunotherapies

June 19, 2025

Pierre Fabre Laboratories Acquires Worldwide Rights for PFL-721 and PFL-241, Expanding its Oncology Portfolio

June 16, 2025

Medtronic Announces MiniMed as Name for Planned New Diabetes Company

June 13, 2025

BioNTech to Acquire CureVac in $1.25 Billion All-Stock Acquisition

June 12, 2025

Quell Therapeutics and AstraZeneca Advance CAR-Treg Cell Therapy for Inflammatory Bowel Disease

June 10, 2025

Sanofi Acquires Vigil Neuroscience to Expand Alzheimer's Disease Pipeline

May 22, 2025

CRISPR and Sirius Therapeutics Partner to Develop siRNA Therapies for Thromboembolic Disorders

May 20, 2025

Carlyle and SK Capital Complete Acquisition of bluebird bio

May 6, 2025

Repare Therapeutics Out-Licenses Discovery Platforms to DCx Biotherapeutics

May 2, 2025

Home/Insights/Mregers And Acquisitions